| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 77.0 | ¤1,019,830 | US |
| JNJ | Johnson & Johnson | 51.6 | ¤556,766 | US |
| MRK | Merck & Co., Inc. | 54.7 | ¤296,971 | US |
| AZN.GB | AstraZeneca PLC | 60.0 | ¤292,066 | GB |
| NOVO.B.DK | Novo Nordisk A/S Class B | 76.4 | ¤201,030 | DK |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 326030.KR | SK Biopharmaceuticals Co., Ltd. | 79.5 | ¤4,959 | KR |
| YPSN.CH | Ypsomed Holding AG | 70.4 | ¤5,519 | CH |
| 4151.JP | Kyowa Kirin Co., Ltd. | 66.8 | ¤8,015 | JP |
| HALO | Halozyme Therapeutics, Inc. | 73.6 | ¤8,143 | US |
| ALK.B.DK | ALK-abello A/S Class B | 73.1 | ¤9,191 | DK |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| NOVO.B.DK | Novo Nordisk A/S Class B | 76.4 | 38 | DK |
| AMGN | Amgen Inc. | 62.2 | 31 | US |
| ISRG | Intuitive Surgical, Inc. | 72.2 | 27 | US |
| RMD | ResMed Inc. | 67.4 | 25 | US |
| JNJ | Johnson & Johnson | 51.6 | 24 | US |
| LLY | Eli Lilly and Company | 77.0 | 23 | US |
| 4507.JP | Shionogi & Co., Ltd. | 70.4 | 22 | JP |
| BMY | Bristol-Myers Squibb Company | 61.9 | 22 | US |
| 4519.JP | Chugai Pharmaceutical Co., Ltd. | 65.6 | 21 | JP |
| 7741.JP | HOYA CORPORATION | 68.5 | 21 | JP |
| Average Market Cap | ¤82,486 |
| Median Market Cap | ¤24,226 |
| Avg. 3 Mo. Dollar Vol. | ¤341,373,766 |
| Avg. 3 Mo. Trading Vol. | 2,595,054 |
| Last Rebalance Date | 03/23/2026 |
| Companies Replaced | 11 |
| Biggest Industry Increase | Medical Specialties |
| Biggest Industry Decrease | Pharmaceuticals: Major |
| Trailing P/E Ratio (12 Mo.) | 24.7 |
| Forward P/E Ratio (12 Mo.) | 19.0 |
| Price/Book Ratio | 6.4 |
| Avg. Revenue Chg. - 3 Yr | 40.9% |
| Avg. Op. Income Chg. - 3 Yr. | 92.0% |
| Avg. EPS Growth - 3 Yr. | 25.3% |
| Avg. EPS Growth - 1 Yr. | 16.7% |
| Avg. Operating Margin | 25.9% |
| Avg. LT Debt to Total Capital | 23.6% |
| Avg. Return on Equity | 23.0% |
| Dividend Yield | 0.4% |
| Developed Markets (ex-Australia) Health Care Index | 67.38 |
| United States Of America | 58.0% |
| Japan | 14.0% |
| Korea, Republic Of | 6.0% |
| Denmark | 4.0% |
| United Kingdom | 4.0% |
| Israel | 2.0% |
| Finland | 2.0% |
| France | 2.0% |
| Belgium | 2.0% |
| Switzerland | 2.0% |
| Netherlands | 2.0% |
| New Zealand | 2.0% |
